Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ding, Xiao Qing ^a   Ge, Peng Cheng ^a   Liu, Zhe ^a   Jia, Heng ^b   Chen, Xi ^c   An, Feng Hui ^d   Li, Li Hua ^d   Chen, Zhao Hong ^d   Mao, Hong Wei ^d   Li, Zhao Yang ^a   Gu, Yan ^a   Zhu, Tie Bing ^a   Li, Chun Jian ^a   Wang, Lian Sheng ^a   Ma, Wen Zhu ^a   Yang, Zhi Jian ^a   Jia, En Zhi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

^d Meteorological Bureau of Ili Kazak Autonomous Prefecture   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MIRN125 MICRORNA, HUMAN;

AGE; AGED; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; CORONARY DISEASE; DIET RESTRICTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE;

AGE FACTORS; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; CORONARY DISEASE; CREATININE; FASTING; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84943594533     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14925     Document Type: Article

References (63)

1. Sayed, A. S., Xia, K., Salma, U., Yang, T. & Peng, J. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 23, 503-10 (2014).
2. Schober, A., Thum, T. & Zernecke, A. MicroRNAs in vascular biology-metabolism and atherosclerosis. Thromb Haemost. 107, 603-604 (2012).
3. Schroen, B. & Heymans, S. Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res. 93, 605-613 (2012).
4. Urbich, C., Kuehbacher, A. & Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 79, 581-588 (2008).
5. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
6. Sonkoly, E., Stahle, M. & Pivarcsi, A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin CancerBiol. 18, 131-140 (2008).
7. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003).
8. Lim, L. P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773 (2005).
9. Bronze-da-Rocha, E. MicroRNAs Expression Profiles in Cardiovascular Diseases. Biomed Res Int. 2014, 985408 (2014).
10. Zeller, T. et al. Blankenberg S. Assessment of microRNAs in patients with unstable angina pectoris. Eur Heart J. 35, 2106-14 (2014).
11. Yang, Q. & Khoury, M. J. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev. 19, 33-43 (1997).
12. Judkins, M. P. A percutaneous transfemoral technique. Radiology 89, 815-821 (1967).
13. Sun, X. et al. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J. 10, 16 (2012).
14. Gensini, G. G. A more meaningful scoring system for determinating the severity of coronary heart disease. Am J Cardiol. 51, 606 (1983).
15. D'Alessandra, Y. et al. Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina. PloS One 8, e80345 (2013).
16. Lu, H. Q., He, Z. Q., Fan, M. & Wu, Z. G. Circulating miR-214 is associated with the severity of coronary artery disease. J Geriatr Cardiol. 10, 34-8 (2013).
17. Ren, J. et al. Signature of Circulating MicroRNAs as Potential Biomarkers in Vulnerable Coronary Artery Disease. PLoS One. 8, e80738 (2013).
18. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circulation research 107, 677-84 (2010).
19. Goettsch, C. et al. miR-125b Regulates Calcification of Vascular Smooth Muscle Cells. The American Journal of Pathology 179, 1594-1600 (2011).
20. Sun, Y. M., Lin, K. Y. & Chen, Y. Q. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol. 6, 6 (2013).
21. Wang, X. et al. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovascular research 102, 385-95 (2014).
22. Ren, D. et al. SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages. Biochimica et biophysica acta 1832, 336-46 (2013).
23. Wang, C. et al. Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility. Clin Chem. 57, 1722-3 (2011).
24. Zhang, C. et al. Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma. Clin Chem. 56, 1871-9 (2010).
25. Chen, X. et al. A Combination of Let-7d, Let-7g and Let-7i Serves as a Stable Reference for Normalization of Serum MicroRNAs. PLoS One 8, e79652 (2013).
26. Devaux, Y. et al. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem. 58, 559-67 (2012).
27. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3, 1101-8 (2008).
28. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95, 14863-8 (1998).
29. Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (1982).
30. Assman, S. F., Hosmer, D. W., Lemeshow, S. & Mundt, K. A. Confidence intervals for measures of interaction. Epidemiology 7, 286-290 (1996).
31. Rodríguez-Rodero, S., Fernández-Morera, J. L., Fernandez, A. F., Menéndez-Torre, E. & Fraga, M. F. Epigenetic regulation of aging. Discov Med. 10, 225-33 (2010).
32. D'Aquila, P., Rose, G., Bellizzi, D. & Passarino, G. Epigenetics and aging. Maturitas. 74, 130-6 (2013).
33. Dimmeler, S. & Nicotera, P. MicroRNAs in age-related diseases. EMBO Mol Med. 5, 180-90 (2013).
34. López-Otín, C., Blasco, M. A., Partridge, L., Serrano M. & Kroemer, G. The hallmarks of aging. Cell. 153, 1194-217 (2013).
35. Inukai, S. & Slack, F. MicroRNAs and the genetic network in aging. J Mol Biol. 425, 3601-8 (2013).
36. Van Rooij, E. The art of microRNA research. Circ Res 108, 219-234 (2011).
37. Small, E. M., Frost, R. J. & Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121, 1022-1032 (2010).
38. Liang, Y., Ridzon, D., Wong, L. & Chen, C. Characterization of microRNA expression in normal human tissues. BMC Genomics 8, 166 (2007).
39. Luo, X., Zhang, H., Xiao, J. & Wang, Z. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem. 25, 571-586 (2010).
40. Bostjancic, E., Zidar, N., Stajer, D. & Glavac, D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115, 163-9 (2010).
41. D'Alessandra Y. et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 31, 2765-2773 (2010).
42. Wang, E. et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation. J Cardiothorac Surg. 8, 165 (2013).
43. Yao, Y. et al. Plasma Levels of MicroRNA-499 Provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients. PLoS One. 9, e104618 (2014).
44. Sucharov, C., Bristow, M. R. & Port, J. D. miRNA expression in the failing human heart functional correlates. J Mol Cell Cardiol. 45, 185-92 (2008).
45. Ferreira, L. R. et al. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy. Int J Cardiol. 175, 409-17 (2014).
46. Pogue, A. I. et al. MicroRNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett. 476, 18-22 (2010).
47. Guan, Y., Yao, H., Zheng, Z., Qiu, G. & Sun, K. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Int J Cancer 128, 2274-2283 (2010).
48. Huang, L. et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 128, 1758-1769 (2011).
49. Mar-Aguilar, F. et al. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac J Clin Oncol. 9, 53-9 (2013).
50. Sonoki, T., Iwanaga, E., Mitsuya, H. & Asou, N. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobul in heavy chain gene locus in a patient with precursor B-cell acute lymphoblasticleukemia. Leukemia 19, 2009-2010 (2005).
51. Chapiro, E. et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 24, 1362-1364 (2010).
52. Lukiw, W. J. & Alexandrov, P. N. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46, 11-19 (2012).
53. Greco, S. et al. Deregulated microRNAs in myotonic dystrophy type 2. PLoS One. 7, e39732 (2012).
54. Huang, Y. et al. Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers 17, 435-440 (2012).
55. Van Pottelberge, G. R. et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 183, 898-906 (2011).
56. Chen, N. X. et al. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease(CKD). PLoS One. 8, e64558 (2013).
57. Sepramaniam, S. et al. Circulating microRNAs as biomarkers of acute stroke. Int J Mol Sci 15, 1418-32 (2014).
58. Ortega, F. J. et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 59, 781-92 (2013).
59. Huang, S. et al. Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations. Circ Cardiovasc Genet. 7, 189-98 (2014).
60. Li, D. et al. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens. 28, 1646-54 (2010).
61. Kurihara, Y. et al. Aortic arch malformations and ventricular septal defect in mice deficient inendothelin-1. J Clin Invest. 96, 293-300 (1995).
62. Ito, H. et al. Endothelin-1is an autocrine/paracrine factor in the mechanism of angiotensinII-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 92, 398-403 (1993).
63. Barton, M. et al. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 95, 14367-14372 (1998).